Transactions
Nov. 25, 2003
Cephalon Wins Cima With $515 Million Transaction
Following a three-month bidding war among various suitors, Cima Labs Inc. has signed a deal to merge with Cephalon Inc. Under the agreement announced Nov. 3, Cephalon will buy all of Cima's outstanding common shares for $34 per share in cash, valuing the transaction at $515 million. The deal displaces a merger agreement that Cima had struck in August with Aaipharma Inc., a stock swap that was valued at $360 million.
Under the agreement announced Nov. 3, Cephalon will buy all of Cima's outstanding common shares for $34 per share in cash, valuing the transaction at $515 million. The deal displaces a merger agreem...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In